Abstract:Background Alzheimer's disease and related dementias (ADRD) and Parkinson's disease (PD) are the most common neurodegenerative conditions. These central nervous system disorders impact both the structure and function of the brain and may lead to imaging changes that precede symptoms. Patients with ADRD or PD have long asymptomatic phases that exhibit significant heterogeneity. Hence, quantitative measures that can provide early disease indicators are necessary to improve patient stratification, clinical care, and clinical trial design. This work uses machine learning techniques to derive such a quantitative marker from T1-weighted (T1w) brain Magnetic resonance imaging (MRI). Methods In this retrospective study, we developed machine learning (ML) based disease-specific scores based on T1w brain MRI utilizing Parkinson's Disease Progression Marker Initiative (PPMI) and Alzheimer's Disease Neuroimaging Initiative (ADNI) cohorts. We evaluated the potential of ML-based scores for early diagnosis, prognosis, and monitoring of ADRD and PD in an independent large-scale population-based longitudinal cohort, UK Biobank. Findings 1,826 dementia images from 731 participants, 3,161 healthy control images from 925 participants from the ADNI cohort, 684 PD images from 319 participants, and 232 healthy control images from 145 participants from the PPMI cohort were used to train machine learning models. The classification performance is 0.94 [95% CI: 0.93-0.96] area under the ROC Curve (AUC) for ADRD detection and 0.63 [95% CI: 0.57-0.71] for PD detection using 790 extracted structural brain features. The most predictive regions include the hippocampus and temporal brain regions in ADRD and the substantia nigra in PD. The normalized ML model's probabilistic output (ADRD and PD imaging scores) was evaluated on 42,835 participants with imaging data from the UK Biobank. There are 66 cases for ADRD and 40 PD cases whose T1 brain MRI is available during pre-diagnostic phases. For diagnosis occurrence events within 5 years, the integrated survival model achieves a time-dependent AUC of 0.86 [95% CI: 0.80-0.92] for dementia and 0.89 [95% CI: 0.85-0.94] for PD. ADRD imaging score is strongly associated with dementia-free survival (hazard ratio (HR) 1.76 [95% CI: 1.50-2.05] per S.D. of imaging score), and PD imaging score shows association with PD-free survival (hazard ratio 2.33 [95% CI: 1.55-3.50]) in our integrated model. HR and prevalence increased stepwise over imaging score quartiles for PD, demonstrating heterogeneity. As a proxy for diagnosis, we validated AD/PD polygenic risk scores of 42,835 subjects against the imaging scores, showing a highly significant association after adjusting for covariates. In both the PPMI and ADNI cohorts, the scores are associated with clinical assessments, including the Mini-Mental State Examination (MMSE), Alzheimer's Disease Assessment Scale-cognitive subscale (ADAS-Cog), and pathological markers, which include amyloid and tau. Finally, imaging scores are associated with polygenic risk scores for multiple diseases. Our results suggest that we can use imaging scores to assess the genetic architecture of such disorders in the future. Interpretation Our study demonstrates the use of quantitative markers generated using machine learning techniques for ADRD and PD. We show that disease probability scores obtained from brain structural features are useful for early detection, prognosis prediction, and monitoring disease progression. To facilitate community engagement and external tests of model utility, an interactive app to explore summary level data from this study and dive into external data can be found here https://ndds-brainimaging-ml.streamlit.app. As far as we know, this is the first publicly available cloud-based MRI prediction application. Funding US National Institute on Aging, and US National Institutes of Health.

The impact of MRI image quality on statistical and predictive analysis on voxel based morphology

Studying the Effects of Sex-related Differences on Brain Age Prediction using brain MR Imaging

Negligible effect of brain MRI data preprocessing for tumor segmentation

Analysing race and sex bias in brain age prediction

Feature robustness and sex differences in medical imaging: a case study in MRI-based Alzheimer's disease detection

Quantitative Brain Morphometry of Portable Low-Field-Strength MRI Using Super-Resolution Machine Learning

Simple statistical methods for unsupervised brain anomaly detection on MRI are competitive to deep learning methods

Learning brain MRI quality control: a multi-factorial generalization problem

Quality assessment and control of unprocessed anatomical, functional, and diffusion MRI of the human brain using MRIQC

A Statistical Analysis of Brain Morphology Using Wild Bootstrapping

Clinical Prediction from Structural Brain MRI Scans: A Large-Scale Empirical Study

Prediction, prognosis and monitoring of neurodegeneration at biobank-scale via machine learning and imaging

Interpretation of 3D CNNs for Brain MRI Data Classification

Brain morphometrics correlations with age among 352 participants imaged with both 3T and 7T MRI: 7T improves statistical power and reduces required sample size

Rethinking Medical Anomaly Detection in Brain MRI: An Image Quality Assessment Perspective

Location, location, location– choice of Voxel-Based Morphometry processing pipeline drives variability in the location of neuroanatomical brain markers

Quality Assessment of MRI-Radiomics-Based Machine Learning Methods in Classification of Brain Tumors: Systematic Review

Machine learning applied to brain imaging data

Validation of Deep Learning Techniques for Quality Augmentation in Diffusion MRI for Clinical Studies

Increasing Power for Voxel-Wise Genome-Wide Association Studies: the Random Field Theory, Least Square Kernel Machines and Fast Permutation Procedures.

Machine Learning with Multi-Site Imaging Data: An Empirical Study on the Impact of Scanner Effects